U.S.Sucralfate Market, by Formulation (Tablet and Liquid Suspension), by Indication(Gastric Ulcers, Duodenal Ulcers, Gastro Esophageal Reflux Disease (GERD), andOthers Indications), by Distribution Channel (Hospital Pharmacy, RetailPharmacy, and Online Pharmacy), and by State (Illinois, Texas, New York,California, and Others) was valued at US$ 296.2 million in 2017, and isprojected to exhibit a CAGR of 3.1% over the forecast period (2018–2026), ashighlighted in a new report published by Coherent Market Insights.
Increasing product approval andproduct launch by market players is expected to augment the market growth
Key players in the market andgovernment authorities are focused on updating the product information andcreating awareness, in order to avoid any serious side effect of sucralfate andto address the critical unmet needs of patients. For instance, in August 2017,Teva Pharmaceutical Industries, Ltd. and Mylan, Inc., product Carafate receivedthe U.S. Food and Drug Administration approval for change in the labellinginformation. The warning and precaution part of labelling was updated by themanufacturer which included the risk such as pulmonary and cerebral emboliowing to the inappropriate administration of Carafate intravenously.
Moreover, increasing number ofprescriptions for different indications every year is expected to propel growthof the U.S. sucralfate market. For instance, according to the MedicalExpenditure Panel Survey (MEPS) report of 2019, 2 million prescriptions ofsucralfate were sold in the U.S. in 2016 for different indications such asstomach ulcers, gastro-esophageal reflux disease, and others.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2975
Browse 22 Market Data Tables and17 Figures spread through 129 Pages and in-depth TOC on ‘U.S. SucralfateMarket’- Forecast to 2026, by Formulation (Tablet and Liquid Suspension), byIndication (Gastric Ulcers, Duodenal Ulcers, Gastro Esophageal Reflux Disease,and Others Indications), by Distribution Channel (Hospital Pharmacy, RetailPharmacy, and Online Pharmacy), and by State (Illinois, Texas, New York,California, and Others).
Furthermore, increasing geriatricpopulation and increasing incidences of gastric diseases in geriatricpopulation in the U.S. is expected to boost growth of the market over theforecast period. For instance, according to the report on ‘Aging in UnitedStates’ in 2016, the number of Americans aged 65 years and above older areprojected to double from 46 million in 2016 to over 98 million by 2060
Key Takeaways of the U.S.Sucralfate Market:
The U.S. sucralfate market is expectedto exhibit a CAGR of 3.1% over the forecast period, owing to increasingprevalence of peptic ulcers and duodenal in the U.S. For instance, according tothe American Association for the Study of Liver Diseases report of 2018, in theU.S., peptic ulcer disease (PUD) affects around 4.5 million people, annually inthe U.S.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/us-sucralfate-market-2975
Among formulation, the tabletsegment held a dominant position in the U.S. sucralfate market in 2018, owingto recommendation of tablet in various types of gastric ulcers. For instance,sucralfate tablets are indicated for the treatment of duodenal andnon-malignant gastric ulcer. They are also indicated for prophylaxis ofduodenal ulcer recurrence.
Among distribution channel, theretail pharmacies segment held a dominant position in the U.S. sucralfatemarket in 2018, owing to increasing number of retail or independent pharmacies.For instance, according to PLOS Journal, August 2017, the number of independentpharmacies in the U.S. exhibited 3.8% growth from 22,737 (2007) to 23,596(2015).
Key players operating in the U.S.sucralfate market include Teva Pharmaceutical Industries Ltd., Allergan plc,Vertice Pharma LLC, and Pharmaceutical Associates Inc.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2975
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
